Cargando…

Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody features

OBJECTIVES: As the world transitions into a new era of the COVID‐19 pandemic in which vaccines become available, there is an increasing demand for rapid reliable serological testing to identify individuals with levels of immunity considered protective by infection or vaccination. METHODS: We used 34...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rowntree, Louise C, Chua, Brendon Y, Nicholson, Suellen, Koutsakos, Marios, Hensen, Luca, Douros, Celia, Selva, Kevin, Mordant, Francesca L, Wong, Chinn Yi, Habel, Jennifer R, Zhang, Wuji, Jia, Xiaoxiao, Allen, Lily, Doolan, Denise L, Jackson, David C, Wheatley, Adam K, Kent, Stephen J, Amanat, Fatima, Krammer, Florian, Subbarao, Kanta, Cheng, Allen C, Chung, Amy W, Catton, Mike, Nguyen, Thi HO, van de Sandt, Carolien E, Kedzierska, Katherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916820/ https://www.ncbi.nlm.nih.gov/pubmed/33680466 http://dx.doi.org/10.1002/cti2.1258

Ejemplares similares

Suboptimal SARS-CoV-2−specific CD8(+) T cell response associated with the prominent HLA-A*02:01 phenotype
por: Habel, Jennifer R., et al.
Publicado: (2020)

Integrated immune dynamics define correlates of COVID-19 severity and antibody responses
por: Koutsakos, Marios, et al.
Publicado: (2021)

Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
por: Thevarajan, Irani, et al.
Publicado: (2020)

Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance
por: Nicholson, Suellen, et al.
Publicado: (2021)

SARS‐CoV‐2‐specific CD8(+) T‐cell responses and TCR signatures in the context of a prominent HLA‐A*24:02 allomorph
por: Rowntree, Louise C, et al.
Publicado: (2021)

Uncomplicated Cystitis in an Adult Male Following Influenza B Virus Infection
por: Allen, Robert J., et al.
Publicado: (2017)

CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity
por: Nguyen, Thi H.O., et al.
Publicado: (2021)

Systems serology detects functionally distinct coronavirus antibody features in children and elderly
por: Selva, Kevin J., et al.
Publicado: (2021)

T Cell Epitope Discovery in the Context of Distinct and Unique Indigenous HLA Profiles
por: Hensen, Luca, et al.
Publicado: (2022)

The ABC of Major Histocompatibility Complexes and T Cell Receptors in Health and Disease
por: Kedzierska, Katherine, et al.
Publicado: (2020)

Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity
por: Zhang, Wuji, et al.
Publicado: (2021)

Robust immunity to influenza vaccination in haematopoietic stem cell transplant recipients following reconstitution of humoral and adaptive immunity
por: Zhang, Wuji, et al.
Publicado: (2023)

Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbations
por: Habel, Jennifer R., et al.
Publicado: (2023)

Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques
por: Chua, Brendon Y., et al.
Publicado: (2022)

Viral burden, inflammatory milieu and CD8(+) T‐cell responses to influenza virus in a second‐generation thiazolide (RM‐5061) and oseltamivir combination therapy study
por: Nüssing, Simone, et al.
Publicado: (2020)

Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19
por: Barrios, Marilou H., et al.
Publicado: (2023)

Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians
por: Hensen, Luca, et al.
Publicado: (2021)

Back to the Future: Lessons Learned From the 1918 Influenza Pandemic
por: Short, Kirsty R., et al.
Publicado: (2018)

Symptoms and laboratory manifestations of mild COVID-19 in a repatriated cruise ship cohort
por: Bailie, C. R., et al.
Publicado: (2021)

Cross-lineage protection by human antibodies binding the influenza B hemagglutinin
por: Liu, Yi, et al.
Publicado: (2019)

Prospective comprehensive profiling of immune responses to COVID‐19 vaccination in patients on zanubrutinib therapy
por: Nguyen, Thi H. O., et al.
Publicado: (2023)

Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells
por: Nguyen, Thi H.O., et al.
Publicado: (2023)

HLA-B*27:05 alters immunodominance hierarchy of universal influenza-specific CD8(+) T cells
por: Sant, Sneha, et al.
Publicado: (2020)

Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18–55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trial
por: Chappell, Keith J., et al.
Publicado: (2023)

SARS-CoV-2-specific T cell memory with common TCRαβ motifs is established in unvaccinated children who seroconvert after infection
por: Rowntree, Louise C., et al.
Publicado: (2022)

Influenza lineage extinction during the COVID-19 pandemic?
por: Koutsakos, Marios, et al.
Publicado: (2021)

Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
por: Chappell, Keith J, et al.
Publicado: (2021)

Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients
por: Nguyen, Thi H. O., et al.
Publicado: (2021)

Prime-boost, double-dose influenza vaccine immunity in COPD: a pilot observational study
por: Anderson, Gary P., et al.
Publicado: (2023)

SARS-CoV-2 Omicron BA.1 Challenge after Ancestral or Delta Infection in Mice
por: Baz, Mariana, et al.
Publicado: (2022)

High expression of CD38 and MHC class II on CD8(+) T cells during severe influenza disease reflects bystander activation and trogocytosis
por: Jia, Xiaoxiao, et al.
Publicado: (2021)

Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities
por: Zhang, Wuji, et al.
Publicado: (2023)

SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity
por: Zhang, Wuji, et al.
Publicado: (2022)

CD8(+) T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph
por: Hensen, Luca, et al.
Publicado: (2021)

A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2
por: Fulford, Thomas S., et al.
Publicado: (2021)

Defective Severe Acute Respiratory Syndrome Coronavirus 2 Immune Responses in an Immunocompromised Individual With Prolonged Viral Replication
por: Gordon, Claire L, et al.
Publicado: (2021)

Special Issue—Immunity to Influenza Viruses
por: Koutsakos, Marios, et al.
Publicado: (2022)

Immunological imprinting: Understanding COVID-19
por: Koutsakos, Marios, et al.
Publicado: (2023)

Recalling the Future: Immunological Memory Toward Unpredictable Influenza Viruses
por: Auladell, Maria, et al.
Publicado: (2019)

Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection
por: Farr, Ryan J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f3cgtgg7krjhd05590km0hbo9n